NHS to fast-track cancer drugs that target genetic mutations
The NHS is preparing to fast-track the introduction of ‘game [...]
Cytoreductive surgery with immunotherapy for kidney cancer patients
In this video clip, Professor Eric Jonasch, Medical Oncologist, Division [...]
Radical versus partial nephrectomy and subsequent hypertension risk
In a recent study, the data from a database were [...]
Nivolumab-ipilimumab combination shows promise for kidney cancer brain metastases
An interim analysis of study Checkmate 920 has shown that [...]
Genetic mutations associated with survival in immunotherapy-treated kidney cancer patients
A recent study of patients with solid tumours treated with [...]
Long-term surveillance of small renal masses is safe
In a recent study published in Journal of Urology and [...]
Patient reported experience for patients with kidney cancer
In this video interview from Practice Update, Dr Eric Jonasch, [...]
Stereotactic radiosurgery is successful for RCC brain metastases
A recent study of 362 patients with brain metastases from [...]
Low PD-L1 associated with long term response to sunitinib
Researchers from France have conducted a study to show that [...]
SMC approves nivolumab plus ipilimumab combination for advanced RCC
We are delighted to announce that the Scottish Medicines Consortium [...]
